CN Stock MarketDetailed Quotes

301277 Newland Pharmaceutical

Watchlist
  • 13.65
  • -0.25-1.80%
Market Closed Jun 20 15:00 CST
3.82BMarket Cap22.71P/E (TTM)

Newland Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
6.98%184.58M
3.84%651.44M
9.33%490.1M
-3.78%334.15M
7.54%172.54M
22.09%627.36M
37.06%448.29M
33.82%347.27M
39.43%160.45M
18.64%513.84M
Operating revenue
6.98%184.58M
3.84%651.44M
9.33%490.1M
-3.78%334.15M
7.54%172.54M
22.09%627.36M
37.06%448.29M
33.82%347.27M
39.43%160.45M
18.64%513.84M
Other operating revenue
----
23.34%7.59M
----
8.61%3.28M
----
25.30%6.15M
----
31.14%3.02M
----
45.44%4.91M
Total operating cost
-0.48%127.02M
1.45%492.35M
2.80%357.81M
-8.12%241.3M
7.00%127.64M
30.11%485.33M
43.79%348.05M
43.60%262.62M
119.29M
27.67%373.02M
Operating cost
-2.05%104.17M
-2.99%391.92M
-0.56%290.47M
-12.12%198.66M
2.19%106.36M
31.25%404.01M
50.79%292.1M
52.08%226.06M
--104.08M
30.26%307.82M
Operating tax surcharges
-4.59%1.62M
-5.89%6.57M
-2.21%5.41M
-17.04%3.68M
-15.04%1.69M
9.12%6.99M
32.64%5.53M
34.68%4.43M
--1.99M
9.87%6.4M
Operating expense
36.48%821.58K
80.23%4.86M
44.81%2.51M
15.82%1.36M
19.32%601.97K
28.32%2.7M
26.55%1.73M
43.74%1.17M
--504.48K
15.59%2.1M
Administration expense
-14.55%9.57M
9.66%39.62M
31.54%30.76M
30.01%19.82M
58.23%11.2M
22.65%36.13M
5.42%23.38M
-2.29%15.25M
--7.08M
25.47%29.46M
Financial expense
-406.64%-1.15M
-147.19%-2.6M
-119.30%-934.65K
-114.42%-491.71K
-113.92%-226.29K
-17.28%5.5M
-0.49%4.84M
10.34%3.41M
--1.63M
61.40%6.65M
-Interest expense (Financial expense)
-43.41%33.22K
-98.07%132.85K
-90.11%524.59K
-78.45%776.94K
-96.48%58.7K
2.63%6.88M
9.46%5.31M
19.68%3.61M
--1.67M
76.57%6.71M
-Interest Income (Financial expense)
-223.10%-1.14M
-130.40%-2.7M
-298.02%-1.42M
-397.40%-936.9K
-304.71%-353.17K
-357.88%-1.17M
-102.44%-357.21K
-132.21%-188.36K
---87.26K
-210.70%-256.35K
Research and development
49.59%11.99M
73.19%51.96M
44.65%29.61M
48.54%18.28M
99.95%8.02M
45.72%30M
29.92%20.47M
7.54%12.3M
--4.01M
-0.15%20.59M
Credit Impairment Loss
-119.23%-659.41K
257.71%3.52M
583.45%2.76M
175.70%3.18M
263.13%3.43M
79.94%-2.23M
-153.50%-571.06K
-183.41%-4.2M
---2.1M
-404.55%-11.13M
Asset Impairment Loss
---862.61K
---914.6K
---588.01K
---248.41K
----
----
----
----
----
----
Other net revenue
-64.54%2.93M
3,959.30%23.67M
5,006.69%16.8M
468.07%12.5M
518.20%8.26M
107.03%583.09K
-90.37%329.07K
-86,133.04%-3.4M
-1.98M
-1,578.75%-8.3M
Fair value change income
45.59%-228.62K
-96.97%41.06K
-0.36%142.48K
-783.30%-728.81K
-779.42%-420.17K
715.67%1.36M
39.07%143K
191.21%106.66K
--61.84K
--166.13K
Invest income
-30.21%3.62M
10,030.79%16.92M
--13.74M
--9.96M
--5.18M
7,725.57%167.03K
----
----
----
--2.13K
Asset deal income
----
115.12%66.94K
----
----
----
-114.11%-442.73K
---442.73K
----
----
-75.87%-206.78K
Other revenue
1,398.25%1.06M
132.58%4.04M
-37.53%749.51K
-51.85%335.34K
10.25%70.97K
-39.46%1.74M
-46.51%1.2M
-51.59%696.44K
--64.37K
56.77%2.87M
Operating profit
13.77%60.49M
28.14%182.76M
48.24%149.09M
29.65%105.35M
35.68%53.17M
7.63%142.62M
13.72%100.57M
6.04%81.25M
10.53%39.19M
-5.65%132.51M
Add:Non operating Income
-89.88%1.7K
-98.00%13.97K
-93.23%47.06K
-97.41%18.02K
-88.61%16.8K
1,695.44%698.42K
4,238.03%695.24K
5,302.62%694.98K
--147.51K
-72.80%38.9K
Less:Non operating expense
28.72%173.95K
269.54%1.61M
269.63%929.01K
141.22%187.12K
--135.14K
-29.62%434.77K
-54.02%251.34K
-80.81%77.57K
----
-80.48%617.72K
Total profit
13.70%60.32M
26.79%181.16M
46.72%148.21M
28.47%105.18M
34.87%53.05M
8.30%142.88M
14.91%101.01M
7.39%81.87M
10.95%39.33M
-4.00%131.94M
Less:Income tax cost
-24.87%4.93M
114.45%23.96M
3.41%12.55M
13.41%11.97M
21.09%6.56M
-34.70%11.17M
9.32%12.14M
4.09%10.56M
--5.42M
-9.80%17.11M
Net profit
19.15%55.39M
19.36%157.2M
52.63%135.66M
30.70%93.2M
37.07%46.49M
14.70%131.71M
15.72%88.88M
7.90%71.31M
9.66%33.91M
-3.07%114.82M
Net profit from continuing operation
----
19.36%157.2M
52.63%135.66M
30.70%93.2M
----
14.70%131.71M
--88.88M
--71.31M
--33.91M
--114.82M
Less:Minority Profit
-128.32%-530.5K
-197.82%-1.78M
-147.86%-1.03M
-86.72%-510.6K
-67.19%-232.35K
-286.25%-596.75K
-391.37%-413.62K
-9,096.05%-273.46K
---138.97K
---154.5K
Net profit of parent company owners
19.69%55.92M
20.16%158.98M
53.07%136.68M
30.91%93.71M
37.19%46.72M
15.07%132.3M
16.13%89.29M
8.30%71.58M
10.11%34.05M
-2.94%114.98M
Earning per share
Basic earning per share
21.74%0.28
-8.14%0.79
-23.47%0.6833
-34.72%0.47
-32.35%0.23
-25.22%0.86
15.96%0.8929
9.09%0.72
--0.34
-3.36%1.15
Diluted earning per share
21.74%0.28
-8.14%0.79
-23.47%0.6833
-34.72%0.47
-32.35%0.23
-25.22%0.86
15.96%0.8929
9.09%0.72
--0.34
-3.36%1.15
Other composite income
Total composite income
19.15%55.39M
19.36%157.2M
52.63%135.66M
30.70%93.2M
37.07%46.49M
14.70%131.71M
15.72%88.88M
7.90%71.31M
33.91M
-3.07%114.82M
Total composite income of parent company owners
19.69%55.92M
20.16%158.98M
53.07%136.68M
30.91%93.71M
37.19%46.72M
15.07%132.3M
16.13%89.29M
8.30%71.58M
--34.05M
-2.94%114.98M
Total composite income of minority owners
-128.32%-530.5K
-197.82%-1.78M
-147.86%-1.03M
-86.72%-510.6K
-67.19%-232.35K
-286.25%-596.75K
-391.37%-413.62K
-9,096.05%-273.46K
---138.97K
---154.5K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 6.98%184.58M3.84%651.44M9.33%490.1M-3.78%334.15M7.54%172.54M22.09%627.36M37.06%448.29M33.82%347.27M39.43%160.45M18.64%513.84M
Operating revenue 6.98%184.58M3.84%651.44M9.33%490.1M-3.78%334.15M7.54%172.54M22.09%627.36M37.06%448.29M33.82%347.27M39.43%160.45M18.64%513.84M
Other operating revenue ----23.34%7.59M----8.61%3.28M----25.30%6.15M----31.14%3.02M----45.44%4.91M
Total operating cost -0.48%127.02M1.45%492.35M2.80%357.81M-8.12%241.3M7.00%127.64M30.11%485.33M43.79%348.05M43.60%262.62M119.29M27.67%373.02M
Operating cost -2.05%104.17M-2.99%391.92M-0.56%290.47M-12.12%198.66M2.19%106.36M31.25%404.01M50.79%292.1M52.08%226.06M--104.08M30.26%307.82M
Operating tax surcharges -4.59%1.62M-5.89%6.57M-2.21%5.41M-17.04%3.68M-15.04%1.69M9.12%6.99M32.64%5.53M34.68%4.43M--1.99M9.87%6.4M
Operating expense 36.48%821.58K80.23%4.86M44.81%2.51M15.82%1.36M19.32%601.97K28.32%2.7M26.55%1.73M43.74%1.17M--504.48K15.59%2.1M
Administration expense -14.55%9.57M9.66%39.62M31.54%30.76M30.01%19.82M58.23%11.2M22.65%36.13M5.42%23.38M-2.29%15.25M--7.08M25.47%29.46M
Financial expense -406.64%-1.15M-147.19%-2.6M-119.30%-934.65K-114.42%-491.71K-113.92%-226.29K-17.28%5.5M-0.49%4.84M10.34%3.41M--1.63M61.40%6.65M
-Interest expense (Financial expense) -43.41%33.22K-98.07%132.85K-90.11%524.59K-78.45%776.94K-96.48%58.7K2.63%6.88M9.46%5.31M19.68%3.61M--1.67M76.57%6.71M
-Interest Income (Financial expense) -223.10%-1.14M-130.40%-2.7M-298.02%-1.42M-397.40%-936.9K-304.71%-353.17K-357.88%-1.17M-102.44%-357.21K-132.21%-188.36K---87.26K-210.70%-256.35K
Research and development 49.59%11.99M73.19%51.96M44.65%29.61M48.54%18.28M99.95%8.02M45.72%30M29.92%20.47M7.54%12.3M--4.01M-0.15%20.59M
Credit Impairment Loss -119.23%-659.41K257.71%3.52M583.45%2.76M175.70%3.18M263.13%3.43M79.94%-2.23M-153.50%-571.06K-183.41%-4.2M---2.1M-404.55%-11.13M
Asset Impairment Loss ---862.61K---914.6K---588.01K---248.41K------------------------
Other net revenue -64.54%2.93M3,959.30%23.67M5,006.69%16.8M468.07%12.5M518.20%8.26M107.03%583.09K-90.37%329.07K-86,133.04%-3.4M-1.98M-1,578.75%-8.3M
Fair value change income 45.59%-228.62K-96.97%41.06K-0.36%142.48K-783.30%-728.81K-779.42%-420.17K715.67%1.36M39.07%143K191.21%106.66K--61.84K--166.13K
Invest income -30.21%3.62M10,030.79%16.92M--13.74M--9.96M--5.18M7,725.57%167.03K--------------2.13K
Asset deal income ----115.12%66.94K-------------114.11%-442.73K---442.73K---------75.87%-206.78K
Other revenue 1,398.25%1.06M132.58%4.04M-37.53%749.51K-51.85%335.34K10.25%70.97K-39.46%1.74M-46.51%1.2M-51.59%696.44K--64.37K56.77%2.87M
Operating profit 13.77%60.49M28.14%182.76M48.24%149.09M29.65%105.35M35.68%53.17M7.63%142.62M13.72%100.57M6.04%81.25M10.53%39.19M-5.65%132.51M
Add:Non operating Income -89.88%1.7K-98.00%13.97K-93.23%47.06K-97.41%18.02K-88.61%16.8K1,695.44%698.42K4,238.03%695.24K5,302.62%694.98K--147.51K-72.80%38.9K
Less:Non operating expense 28.72%173.95K269.54%1.61M269.63%929.01K141.22%187.12K--135.14K-29.62%434.77K-54.02%251.34K-80.81%77.57K-----80.48%617.72K
Total profit 13.70%60.32M26.79%181.16M46.72%148.21M28.47%105.18M34.87%53.05M8.30%142.88M14.91%101.01M7.39%81.87M10.95%39.33M-4.00%131.94M
Less:Income tax cost -24.87%4.93M114.45%23.96M3.41%12.55M13.41%11.97M21.09%6.56M-34.70%11.17M9.32%12.14M4.09%10.56M--5.42M-9.80%17.11M
Net profit 19.15%55.39M19.36%157.2M52.63%135.66M30.70%93.2M37.07%46.49M14.70%131.71M15.72%88.88M7.90%71.31M9.66%33.91M-3.07%114.82M
Net profit from continuing operation ----19.36%157.2M52.63%135.66M30.70%93.2M----14.70%131.71M--88.88M--71.31M--33.91M--114.82M
Less:Minority Profit -128.32%-530.5K-197.82%-1.78M-147.86%-1.03M-86.72%-510.6K-67.19%-232.35K-286.25%-596.75K-391.37%-413.62K-9,096.05%-273.46K---138.97K---154.5K
Net profit of parent company owners 19.69%55.92M20.16%158.98M53.07%136.68M30.91%93.71M37.19%46.72M15.07%132.3M16.13%89.29M8.30%71.58M10.11%34.05M-2.94%114.98M
Earning per share
Basic earning per share 21.74%0.28-8.14%0.79-23.47%0.6833-34.72%0.47-32.35%0.23-25.22%0.8615.96%0.89299.09%0.72--0.34-3.36%1.15
Diluted earning per share 21.74%0.28-8.14%0.79-23.47%0.6833-34.72%0.47-32.35%0.23-25.22%0.8615.96%0.89299.09%0.72--0.34-3.36%1.15
Other composite income
Total composite income 19.15%55.39M19.36%157.2M52.63%135.66M30.70%93.2M37.07%46.49M14.70%131.71M15.72%88.88M7.90%71.31M33.91M-3.07%114.82M
Total composite income of parent company owners 19.69%55.92M20.16%158.98M53.07%136.68M30.91%93.71M37.19%46.72M15.07%132.3M16.13%89.29M8.30%71.58M--34.05M-2.94%114.98M
Total composite income of minority owners -128.32%-530.5K-197.82%-1.78M-147.86%-1.03M-86.72%-510.6K-67.19%-232.35K-286.25%-596.75K-391.37%-413.62K-9,096.05%-273.46K---138.97K---154.5K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg